Institution
University of Colorado Denver
Education•Denver, Colorado, United States•
About: University of Colorado Denver is a education organization based out in Denver, Colorado, United States. It is known for research contribution in the topics: Population & Health care. The organization has 27444 authors who have published 57213 publications receiving 2539937 citations. The organization is also known as: CU Denver & UCD.
Topics: Population, Health care, Poison control, Medicine, Diabetes mellitus
Papers published on a yearly basis
Papers
More filters
Lund University1, University of Colorado Denver2, University of California, San Diego3, University of Grenoble4, Mayo Clinic5, University of Hawaii6, University of Washington7, University of Portland8, University of Melbourne9, University of Medicine and Dentistry of New Jersey10, University of Lyon11, University of Edinburgh12, University College London13, University of Michigan14
TL;DR: The CEAP classification for chronic venous disorders was developed in 1994 by an international ad hoc committee of the American Venous Forum, endorsed by the Society for Vascular Surgery, and incorporated into "Reporting Standards in Venous Disease" in 1995.
1,695 citations
TL;DR: As compared with crizotinib, alectinib showed superior efficacy and lower toxicity in primary treatment of ALK‐positive NSCLC and independent review committee–assessed progression‐free survival were consistent with those for the primary end point.
Abstract: BackgroundAlectinib, a highly selective inhibitor of anaplastic lymphoma kinase (ALK), has shown systemic and central nervous system (CNS) efficacy in the treatment of ALK-positive non–small-cell lung cancer (NSCLC). We investigated alectinib as compared with crizotinib in patients with previously untreated, advanced ALK-positive NSCLC, including those with asymptomatic CNS disease. MethodsIn a randomized, open-label, phase 3 trial, we randomly assigned 303 patients with previously untreated, advanced ALK-positive NSCLC to receive either alectinib (600 mg twice daily) or crizotinib (250 mg twice daily). The primary end point was investigator-assessed progression-free survival. Secondary end points were independent review committee–assessed progression-free survival, time to CNS progression, objective response rate, and overall survival. ResultsDuring a median follow-up of 17.6 months (crizotinib) and 18.6 months (alectinib), an event of disease progression or death occurred in 62 of 152 patients (41%) in ...
1,665 citations
Massachusetts Institute of Technology1, University of California, Riverside2, University of Oregon3, University of Edinburgh4, Celera Corporation5, Texas A&M University6, University of New Mexico7, University of Colorado Denver8, University of Kansas9, University of Florida10, Hebrew University of Jerusalem11, University of Düsseldorf12, Rockefeller University13, Technische Universität München14, University of Kentucky15, University of Texas at Austin16, J. Craig Venter Institute17, University of California, Berkeley18, University of California, Los Angeles19, Sapienza University of Rome20, Flinders University21, Ohio State University22, University of Arizona23, University of Missouri–Kansas City24, Dartmouth College25, University of Leeds26, California State Polytechnic University, Pomona27, Oregon Health & Science University28
TL;DR: A high-quality draft sequence of the N. crassa genome is reported, suggesting that RIP has had a profound impact on genome evolution, greatly slowing the creation of new genes through genomic duplication and resulting in a genome with an unusually low proportion of closely related genes.
Abstract: Neurospora crassa is a central organism in the history of twentieth-century genetics, biochemistry and molecular biology. Here, we
report a high-quality draft sequence of the N. crassa genome. The approximately 40-megabase genome encodes about 10,000
protein-coding genes—more than twice as many as in the fission yeast Schizosaccharomyces pombe and only about 25% fewer
than in the fruitfly Drosophila melanogaster. Analysis of the gene set yields insights into unexpected aspects of Neurospora biology
including the identification of genes potentially associated with red light photobiology, genes implicated in secondary metabolism,
and important differences in Ca21 signalling as compared with plants and animals. Neurospora possesses the widest array of
genome defence mechanisms known for any eukaryotic organism, including a process unique to fungi called repeat-induced
point mutation (RIP). Genome analysis suggests that RIP has had a profound impact on genome evolution, greatly slowing the
creation of new genes through genomic duplication and resulting in a genome with an unusually low proportion of closely related
genes.
1,659 citations
Mohammad H. Forouzanfar1, Lily Alexander1, H. Ross Anderson2, Victoria F Bachman1 +718 more•Institutions (295)
TL;DR: The Global Burden of Disease, Injuries, and Risk Factor study 2013 (GBD 2013) as mentioned in this paper provides a timely opportunity to update the comparative risk assessment with new data for exposure, relative risks, and evidence on the appropriate counterfactual risk distribution.
1,656 citations
[...]
TL;DR: The epidemiology, molecular pathogenesis, diagnosis and staging, and the latest multimodal management of squamous cell carcinoma of the head and neck are reviewed.
1,644 citations
Authors
Showing all 27683 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Matthew Meyerson | 194 | 553 | 243726 |
| Charles A. Dinarello | 190 | 1058 | 139668 |
| Gad Getz | 189 | 520 | 247560 |
| Gordon B. Mills | 187 | 1273 | 186451 |
| Jasvinder A. Singh | 176 | 2382 | 223370 |
| David Haussler | 172 | 488 | 224960 |
| Donald G. Truhlar | 165 | 1518 | 157965 |
| Charles M. Perou | 156 | 573 | 202951 |
| David Cella | 156 | 1258 | 106402 |
| Bruce D. Walker | 155 | 779 | 86020 |
| Marco A. Marra | 153 | 620 | 184684 |
| Thomas E. Starzl | 150 | 1625 | 91704 |
| Marc Humbert | 149 | 1184 | 100577 |
| Rajesh Kumar | 149 | 4439 | 140830 |
| Martin J. Blaser | 147 | 820 | 104104 |